Analystreport

Tenax Therapeutics (NASDAQ:TENX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $20.00 price target on the stock.

Tenax Therapeutics, Inc.  (TENX) 
Last tenax therapeutics, inc. earnings: 11/14 04:31 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.tenaxthera.com